Dr Susanne Arnold talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about a phase II study looking into carfilzomib and irinotecan in relapsed small cell lung cancer. She explains that there were two cohorts:...
Original Article: Carfilzomib and irinotecan in relapsed small cell lung cancer